Skip to content
Disclosery

EXANE DERIVATIVES: XLE position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on XLE, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 762 XLE shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 762 shares
    Change vs previous 13F -59,011 shares

    0.03% of the 13F portfolio, value $54,480.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 59,773 shares
    Change vs previous 13F -46,046 shares

    1.29% of the 13F portfolio, value $4,568,767.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 105,819 shares
    Change vs previous 13F -1,949 shares

    1.43% of the 13F portfolio, value $5,872,742.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 107,768 shares
    Change vs previous 13F -26,592 shares

    1.4% of the 13F portfolio, value $5,613,434.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 134,360 shares
    Change vs previous 13F +23,427 shares

    1.65% of the 13F portfolio, value $7,036,272.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 110,933 shares
    Change vs previous 13F -44,622 shares

    1.64% of the 13F portfolio, value $5,442,132.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 155,555 shares
    Change vs previous 13F -394,493 shares

    1.79% of the 13F portfolio, value $5,895,262.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 550,048 shares
    Change vs previous 13F not available

    5.37% of the 13F portfolio, value $16,475,916.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).